市場調査レポート
商品コード
1481947

魚類ワクチンの欧州市場：地域別分析 - ワクチンタイプ別、用途別、投与経路別、魚種別、予測（～2030年）

Europe Fish Vaccines Market Forecast to 2030 - Regional Analysis - by Vaccine Type, Application, Route of Administration, and Species
表紙：魚類ワクチンの欧州市場：地域別分析 - ワクチンタイプ別、用途別、投与経路別、魚種別、予測（～2030年）

出版日
ページ情報
英文 88 Pages
納期
即納可能
魚類ワクチンの欧州市場：地域別分析 - ワクチンタイプ別、用途別、投与経路別、魚種別、予測（～2030年）
出版日: 2024年02月28日
発行: The Insight Partners
ページ情報: 英文 88 Pages
納期: 即納可能
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

欧州の魚類ワクチンの市場規模は、2022年に1億1,000万米ドルに達し、2022～2030年にかけてCAGR 7.2%で成長し、2030年には1億9,133万米ドルに達すると予測されています。

水産動物由来食品への需要急増が欧州の魚類ワクチン市場を後押し

不健康な食生活は発展途上国でも先進国でも懸念が高まっており、その結果、健康にさまざまな悪影響をもたらしています。そのため、ビタミン、ミネラル、脂質、タンパク質などの多量栄養素が豊富な魚は、健康的な成長と発育のための食事に非常に適しています。さらに、養殖は人間の持続可能な食生活のために高品質のタンパク質を生産する最も効果的な方法であると考えられています。魚の消費による栄養上の利点に関する意識の高まりが、持続可能で高品質かつ健康的な肉製品に対する需要を後押ししています。そのため、魚や魚由来の製品の消費の増加は、魚類ワクチン市場の成長を促進しています。

欧州の魚類ワクチンの市場概要

欧州の魚類ワクチン市場は、ドイツ、英国、フランス、イタリア、スペイン、その他の欧州に区分されます。この地域は魚類ワクチン市場で大きなシェアを占めています。欧州の魚類ワクチン市場は、水産養殖産業の著しい成長、水産動物由来の食品需要の急増、同地域の市場プレイヤーによる魚類ワクチン開発の研究開発活動の活発化などの要因により、予測期間中に大きな成長が見込まれています。水産養殖は英国における主要な食品生産部門のひとつです。英国商務省によると、英国における水産物の購入額は51億4,000万米ドルと推定されています。Innovate UKによると、英国における養殖業の生産額は年間～730.88米ドルです。養殖と漁業を維持することの重要性に関する認識を高めるために、規制当局によって様々なイベントが開催されています。2023年5月には、スコットランドのアビモアで、養殖産業を対象とした英国最大の見本市-Aquaculture UK-が開催されました。この見本市では、魚の健康、よりクリーンな魚の育種、遺伝子選択などにおける革新と持続可能性に焦点が当てられました。

欧州の魚類ワクチン市場の収益と2030年までの予測（100万米ドル）

欧州の魚類ワクチン市場セグメンテーション

欧州の魚類ワクチン市場は、ワクチンタイプ、用途、投与経路、魚種、国に基づいてセグメント化されます。

ワクチンタイプ別では、欧州の魚類ワクチン市場は不活化ワクチン、弱毒生ワクチン、サブユニットワクチン、組み換えベクターワクチン、その他にセグメント化されます。不活化ワクチンセグメントが2022年に最大の市場シェアを占めました。

用途別では、欧州の魚類ワクチン市場は細菌感染、ウイルス感染、寄生虫に区分されます。細菌感染セグメントが2022年に最大の市場シェアを占めました。

投与経路別では、欧州の魚類ワクチン市場は注射ワクチン、浸漬ワクチン、経口ワクチンに区分されます。注射ワクチンセグメントが2022年に最大の市場シェアを占めました。

魚種別では、欧州の魚類ワクチン市場はサケ、マス、ティラピア、その他に区分されます。サケセグメントが2022年に最大の市場シェアを占めました。

国別では、欧州の魚類ワクチン市場は英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州の魚類ワクチン市場シェアは英国が独占。

Elanco Animal Health Inc、Hipra SA、Merck &Co Inc、Phibro Animal Health Corp、Vaxxinova International BV、Zoetis Inc.は、欧州の魚類ワクチン市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 欧州の魚類ワクチン市場

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の魚類ワクチン市場：主要産業力学

  • 市場促進要因
    • 水産養殖産業発展への政府の取り組み
    • 水産動物由来の食品に対する需要の急増
  • 市場抑制要因
    • ワクチン認可のための厳しい規制
  • 市場機会
    • 新規魚類ワクチンの開発
  • 今後の動向
    • 魚類ワクチンの技術的進歩
  • 影響分析

第5章 魚類ワクチン市場 - 欧州市場分析

  • 魚類ワクチンの市場収益、2022～2030年

第6章 魚類ワクチンの欧州市場：収益と予測（～2030年）：ワクチンタイプ別

  • 魚類ワクチンの市場収益シェア：ワクチンタイプ別、2022年・2030年 (%)
  • 不活化ワクチン
  • 弱毒生ワクチン
  • サブユニットワクチン
  • 組み換えベクターワクチン
  • その他

第7章 魚類ワクチンの欧州市場：収益と予測（～2030年）：用途別

  • 魚類ワクチンの市場収益シェア：用途別、2022年・2030年 (%)
  • 細菌感染
  • ウイルス感染
  • 寄生虫感染

第8章 魚類ワクチンの欧州市場：収益と予測（～2030年）：投与経路別

  • 魚類ワクチンの市場収益シェア：投与経路別、2022年・2030年 (%)
  • 注射ワクチン
  • 浸漬ワクチン
  • 経口ワクチン

第9章 魚類ワクチンの欧州市場：収益と予測（～2030年）：魚種別

  • 魚類ワクチンの市場収益シェア：魚種別、2022年・2030年 (%)
  • サーモン
  • マス
  • ティラピア
  • その他

第10章 欧州の魚類ワクチン市場：国別分析

  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • その他の欧州

第11章 魚類ワクチン市場 - 産業情勢

  • 魚類ワクチン市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Zoetis Inc
  • Merck & Co Inc
  • HIPRA SA
  • Phibro Animal Health Corp
  • Vaxxinova International BV
  • Elanco Animal Health Inc

第13章 付録

図表

List Of Tables

  • Table 1. Europe Fish Vaccine Market Segmentation
  • Table 2. Worldwide Fish Production and Consumption in 2022
  • Table 3. Major Bacterial Diseases in Fish
  • Table 4. Major Viral Diseases in Fish
  • Table 5. Major Parasitic Diseases in Fish
  • Table 6. Atlantic Salmon Production 2020
  • Table 7. UK Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 8. UK Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 9. UK Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 10. UK Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 11. Germany Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 12. Germany Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 13. Germany Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 14. Germany Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 15. France Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 16. France Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 17. France Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 18. France Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 19. Italy Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 20. Italy Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 21. Italy Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 22. Italy Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 23. Spain Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 24. Spain Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 25. Spain Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 26. Spain Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 27. Rest of Europe Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 28. Rest of Europe Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 29. Rest of Europe Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 30. Rest of Europe Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 31. Recent Inorganic Growth Strategies in the Fish Vaccine Market
  • Table 32. Recent Organic Growth Strategies in Fish Vaccine Market
  • Table 33. Glossary of Terms, Fish Vaccine Market

List Of Figures

  • Figure 1. Europe Fish Vaccine Market Segmentation, By Country
  • Figure 2. Europe Fish Vaccine Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
  • Figure 5. Europe Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 11. Europe Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 15. Europe Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
  • Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 24. Europe Fish Vaccine Market, by Key Country - Revenue, 2022 (US$ Thousand)
  • Figure 25. Europe Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
  • Figure 26. UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 27. Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 28. France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 29. Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 30. Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 31. Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 32. Growth Strategies in Fish Vaccine Market
目次
Product Code: BMIRE00029703

The Europe fish vaccines market was valued at US$ 110.00 million in 2022 and is expected to reach US$ 191.33 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Surging Demand for Aquatic Animal-Derived Food Products Fuel the Europe Fish Vaccines Market

An unhealthy diet is a growing concern in developing and developed countries, resulting in a variety of negative health consequences. Thus, fish is highly advisable in diet for healthy growth and development as it is rich in vitamins, minerals, lipids, and macronutrients such as proteins. Additionally, it is believed that aquaculture is the most effective way to produce high-quality proteins for a sustainable human diet. Growing awareness regarding the nutritional benefits of fish consumption propels the demand for sustainable, high-quality, and healthy meat products. Therefore, the rising consumption of fish and fish-derived products fuels the fish vaccines market growth.

Europe Fish Vaccines Market Overview

The European fish vaccines market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the fish vaccines market. The European fish vaccines market is expected to witness significant growth during the forecast period due to factors such as the significant growth in aquaculture industry, surging demand for aquatic animal-derived food products, growing research and development activities for fish vaccines development by market players in the region. Aquaculture is one of the key food-production sectors in the UK. According to the Department of Business and Trade (UK), seafood purchase is estimated to be ~US$ 5.14 billion in Great Britain. According to Innovate UK, the production value of the aquaculture industry in the UK is ~US$ 730.88 annually. Various events are organized by regulatory authorities to increase the awareness regarding the importance of maintaining aquaculture and fisheries. In May 2023, the UK's largest trade show-Aquaculture UK-for the community of aquaculture was held in Aviemore, Scotland. This trade show focused on innovation and sustainability in fish health, cleaner fish breeding, genetic selection, and other topics.

Europe Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

Europe Fish Vaccines Market Segmentation

The Europe fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the Europe fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the Europe fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the Europe fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the Europe fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the Europe fish vaccines market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe fish vaccines market share in 2022.

Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the Europe fish vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Europe Fish Vaccine Market

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Fish Vaccine Market - Key Industry Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Government Initiatives to Develop Aquaculture Industry
    • 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
  • 4.2 Market Restraints
    • 4.2.1 Stringent Regulations for Approval of Vaccine
  • 4.3 Market Opportunities
    • 4.3.1 Development of Novel Fish Vaccine
  • 4.4 Future Trends
    • 4.4.1 Technological Advancements in Fish Vaccine
  • 4.5 Impact Analysis:

5. Fish Vaccine Market - Europe Market Analysis

  • 5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030

6. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

  • 6.1 Overview
  • 6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • 6.3 Inactivated Vaccines
    • 6.3.1 Overview
    • 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.4 Live Attenuated Vaccines
    • 6.4.1 Overview
    • 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.5 Subunit Vaccines
    • 6.5.1 Overview
    • 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.6 Recombinant Vector Vaccine
    • 6.6.1 Overview
    • 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

7. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • 7.3 Bacterial Infection
    • 7.3.1 Overview
    • 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.4 Viral Infection
    • 7.4.1 Overview
    • 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.5 Parasitic
    • 7.5.1 Overview
    • 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

8. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

  • 8.1 Overview
  • 8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • 8.3 Injection vaccine
    • 8.3.1 Overview
    • 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.4 Immersion Vaccine
    • 8.4.1 Overview
    • 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.5 Oral Vaccine
    • 8.5.1 Overview
    • 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

9. Europe Fish Vaccine Market - Revenue and Forecast to 2030 - by Species

  • 9.1 Overview
  • 9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
  • 9.3 Salmon
    • 9.3.1 Overview
    • 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.4 Trout
    • 9.4.1 Overview
    • 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.5 Tilapia
    • 9.5.1 Overview
    • 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

10. Europe Fish Vaccine Market - Country Analysis

  • 10.1 Europe Fish Vaccine Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Europe Fish Vaccine Market, by Country
      • 10.1.2.1 UK
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.1.3 UK: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.1.4 UK: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.1.5 UK: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.1.6 UK: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.2 Germany
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.2.3 Germany: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.2.4 Germany: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.2.5 Germany: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.2.6 Germany: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.3 France
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.3.3 France: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.3.4 France: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.3.5 France: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.3.6 France: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.4 Italy
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.4.3 Italy: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.4.4 Italy: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.4.5 Italy: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.4.6 Italy: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.5 Spain
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.5.3 Spain: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.5.4 Spain: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.5.5 Spain: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.5.6 Spain: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.6 Rest of Europe
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.6.3 Rest of Europe: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.6.4 Rest of Europe: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.6.5 Rest of Europe: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.6.6 Rest of Europe: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)

11. Fish Vaccine Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Fish Vaccine Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zoetis Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck & Co Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 HIPRA SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Phibro Animal Health Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Vaxxinova International BV
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Elanco Animal Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms